A naturalistic comparison study of the efficacy and safety of intramuscular olanzapine, intramuscular haloperidol, and intramuscular levomepromazine in acute agitated patients with schizophrenia. (January 2014)
- Record Type:
- Journal Article
- Title:
- A naturalistic comparison study of the efficacy and safety of intramuscular olanzapine, intramuscular haloperidol, and intramuscular levomepromazine in acute agitated patients with schizophrenia. (January 2014)
- Main Title:
- A naturalistic comparison study of the efficacy and safety of intramuscular olanzapine, intramuscular haloperidol, and intramuscular levomepromazine in acute agitated patients with schizophrenia
- Authors:
- Suzuki, Hidenobu
Gen, Keishi
Takahashi, Yuki - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="hup2376-sec-0001" sec-type="section"> <title>Objective</title> <p>This study was a comparative investigation of the clinical efficacy and safety of intramuscular (IM) olanzapine, IM haloperidol, and IM levomepromazine in acute agitated patients with schizophrenia.</p> </sec> <sec id="hup2376-sec-0002" sec-type="section"> <title>Methods</title> <p>The subjects were 122 inpatients. Their clinical symptoms were assessed using Positive and Negative Syndrome Scale Excited Component (PANSS‐EC), PANSS, and Agitation–Calmness Evaluation Scale, and their safety were assessed using the Abnormal Involuntary Movement Scale, Barnes Akathisia Rating Scale (BARS), and Drug‐induced Extrapyramidal Symptoms Scale (DIEPSS).</p> </sec> <sec id="hup2376-sec-0003" sec-type="section"> <title>Results</title> <p>The mean changes from baseline on the PANSS‐EC, Agitation–Calmness Evaluation Scale, Abnormal Involuntary Movement Scale, BARS, and DIEPSS scores were significantly better in both IM olanzapine and IM levomepromazine than in IM haloperidol. Of these, the mean changes from baseline on the BARS and DIEPSS scores were significantly better in IM olanzapine than in IM levomepromazine. The mean change from baseline on the PANSS positive score was significantly better in both IM olanzapine and IM haloperidol than in IM levomepromazine.</p> </sec> <sec id="hup2376-sec-0004" sec-type="section"><abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="hup2376-sec-0001" sec-type="section"> <title>Objective</title> <p>This study was a comparative investigation of the clinical efficacy and safety of intramuscular (IM) olanzapine, IM haloperidol, and IM levomepromazine in acute agitated patients with schizophrenia.</p> </sec> <sec id="hup2376-sec-0002" sec-type="section"> <title>Methods</title> <p>The subjects were 122 inpatients. Their clinical symptoms were assessed using Positive and Negative Syndrome Scale Excited Component (PANSS‐EC), PANSS, and Agitation–Calmness Evaluation Scale, and their safety were assessed using the Abnormal Involuntary Movement Scale, Barnes Akathisia Rating Scale (BARS), and Drug‐induced Extrapyramidal Symptoms Scale (DIEPSS).</p> </sec> <sec id="hup2376-sec-0003" sec-type="section"> <title>Results</title> <p>The mean changes from baseline on the PANSS‐EC, Agitation–Calmness Evaluation Scale, Abnormal Involuntary Movement Scale, BARS, and DIEPSS scores were significantly better in both IM olanzapine and IM levomepromazine than in IM haloperidol. Of these, the mean changes from baseline on the BARS and DIEPSS scores were significantly better in IM olanzapine than in IM levomepromazine. The mean change from baseline on the PANSS positive score was significantly better in both IM olanzapine and IM haloperidol than in IM levomepromazine.</p> </sec> <sec id="hup2376-sec-0004" sec-type="section"> <title>Conclusions</title> <p>The results of this study suggest the possibility that the anti‐agitation effects of IM olanzapine and IM levomepromazine are more rapid than those of IM haloperidol. No worsening of EPS was observed. Our results also suggest that compared with IM levomepromazine, IM olanzapine is safer and affords greater improvement in symptoms. Copyright © 2014 John Wiley &amp; Sons, Ltd.</p> </sec> </abstract> … (more)
- Is Part Of:
- Human psychopharmacology. Volume 29:Number 1(2014:Jan.)
- Journal:
- Human psychopharmacology
- Issue:
- Volume 29:Number 1(2014:Jan.)
- Issue Display:
- Volume 29, Issue 1 (2014)
- Year:
- 2014
- Volume:
- 29
- Issue:
- 1
- Issue Sort Value:
- 2014-0029-0001-0000
- Page Start:
- 83
- Page End:
- 88
- Publication Date:
- 2014-01
- Subjects:
- Psychopharmacology -- Periodicals
Psychotropic drugs -- Periodicals
Psychopharmacology -- Periodicals
Psychotropic Drugs -- pharmacology -- Periodicals
615.78 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
- DOI:
- 10.1002/hup.2376 ↗
- Languages:
- English
- ISSNs:
- 0885-6222
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4336.380000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 4102.xml